2009;33:287 97. 1252. Shimizu T, Ohno T, Ando J, et al. Mid-term results and costs of coronary artery bypass vs drug-eluting stents for unprotected left main coronary artery disease. Circ J. 2010;74:449 55. 1253. Vassiliades T Jr. Enabling technology for minimally invasive coronary artery bypass grafting. Semin Thorac Cardiovasc Surg. 2009;21: 237 44. 1254. Biancari F, Lahtinen J, Ojala R, et al. Spyder aortic connector system in off-pump coronary artery bypass surgery. Ann Thorac Surg. 2007; 84:254 7. 1255. Kempfert J, Opfermann UT, Richter M, et al. Twelve-month patency with the PAS-Port proximal connector device: a single center pro- spective randomized trial. Ann Thorac Surg. 2008;85:1579 84. 1256. Gummert JF, Demertzis S, Matschke K. Six-month angiographic follow-up of the PAS-Port II clinical trial. Ann Thorac Surg. 2006; 81:90 6. 1257. Cai TH, Acuff TE, Bolton JWR, Dizney LR, Poon M. Prospective evaluation of patency and early experience utilizing an automated distal anastomosis device (C-Port). Innovations: Technology & Tech- niques in Cardiothoracic & Vascular Surgery. 2007;2:245 50. Hillis et al 2011 ACCF/AHA CABG Guideline e729 1258. Matschke KE, Gummert JF, Demertzis S, et al. The Cardica C-Port System: clinical and angiographic evaluation of a new device for automated, compliant distal anastomoses in coronary artery bypass grafting surgery a multicenter prospective clinical trial. J Thorac Cardiovasc Surg. 2005;130:1645 52. 1259. Leacche M, Balaguer JM, Byrne JG. Intraoperative grafts assessment. Semin Thorac Cardiovasc Surg. 2009;21:207 12. 1260. Alexander JH, Hafley G, Harrington RA, et al. efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial. JAMA. 2005;294: 2446 54. 1261. Balacumaraswami L, Taggart DP. Intraoperative imaging techniques to assess coronary artery bypass graft patency. Ann Thorac Surg. 2007; 83:2251 7. 1262. 